{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "Gesundheit, New York. Just as snowy winds and freezing temperatures have finally besieged the city, so, too, have high fevers, runny noses, achy joints -- the hallmarks of the cold and flu season -- gripped its residents, by the thousands. Carmen Quinones, 26, sat quietly in an emergency-room chair yesterday, weary eyes focused on the intravenous needle stuck into her right forearm. Four hours and three bags of hydrating saline fluid after her arrival at the Mount Sinai-New York University Medical Center's uptown campus, she was feeling pretty darn good, considering.", "headline": {"main": "That Sniffly, Sneezy, Achy Feeling Again; The Dreaded Cold and Flu Season Is Crowding Emergency Rooms"}, "abstract": "New York City hospital emergency rooms are being inundated with 10 to 50 percent more patients than few weeks ago, thanks largely to flu season that began in earnest in mid-December; scenes at some of area's hospitals discussed; photo (M)", "print_page": "1", "word_count": 1075, "_id": "4fd1e87a8eb7c8105d736bb5", "snippet": "Gesundheit, New York. Just as snowy winds and freezing temperatures have finally besieged the city, so, too, have high fevers, runny noses, achy joints -- the hallmarks of the cold and flu season -- gripped its residents, by the thousands.    Carmen...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/01/09/nyregion/that-sniffly-sneezy-achy-feeling-again-dreaded-cold-flu-season-crowding.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "ZEILBAUER, PAUL"}, {"name": "glocations", "value": "NEW YORK CITY"}, {"name": "subject", "value": "INFLUENZA"}, {"name": "subject", "value": "HOSPITALS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Paul", "lastname": "ZIELBAUER"}], "original": "By PAUL ZIELBAUER"}, "document_type": "article", "pub_date": "1999-01-09T00:00:00Z", "section_name": "Health; New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Arthritis sufferers who want to try Celebrex, a new anti-inflammatory drug that was approved by the Food and Drug Administration last week, may have to pay for the drug themselves, as several of the nation's largest insurers plan to limit coverage of the pill. Two large insurers -- Wellpoint Health Networks Inc. and Aetna U.S. Healthcare -- have restricted the use of Celebrex. The United Healthcare Corporation has given the drug the lowest reimbursement it offers, while Kaiser Permanente of California is considering not covering Celebrex at all.", "headline": {"main": "Some H.M.O.'s Plan Limited Coverage for New Arthritis Drug"}, "abstract": "Arthritis sufferers who want to try Celebrex, anti-inflammatory drug newly approved by Food and Drug Administration, may have to pay for drug themselves; several of nation's largest insurers plan to limit coverage of the pill; Wellpoint Health Networks Inc and Aetna US Healthcare have restricted use; United Healthcare Corp has given drug lowest reimbursement it offers, while Kaiser Permanente is considering not covering drug; some insurers say Celebrex is much more expensive than generic brands, regarded by doctors to be equally effective (M)", "print_page": "18", "word_count": 521, "_id": "4fd20a098eb7c8105d776d73", "snippet": "Arthritis sufferers who want to try Celebrex, a new anti-inflammatory drug that was approved by the Food and Drug Administration last week, may have to pay for the drug themselves, as several of the nation's largest insurers plan to limit coverage of...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/01/08/business/some-hmo-s-plan-limited-coverage-for-new-arthritis-drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "AETNA US HEALTHCARE"}, {"name": "organizations", "value": "KAISER PERMANENTE"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "UNITED HEALTHCARE CORP"}, {"name": "organizations", "value": "WELLPOINT HEALTH NETWORKS INC"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "HEALTH MAINTENANCE ORGANIZATIONS AND MANAGED CARE"}, {"name": "subject", "value": "CELEBREX (DRUG)"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ARTHRITIS AND RHEUMATISM"}], "byline": {"person": [{"firstname": "David", "middlename": "J.", "lastname": "MORROW", "rank": 1, "role": "reported", "organization": ""}], "original": "By DAVID J. MORROW"}, "document_type": "article", "pub_date": "1999-01-08T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 32, "offset": 30, "time": 40}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}